Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 165,351,184
  • Shares Outstanding, K 5,666,593
  • Annual Sales, $ 58,496 M
  • Annual Income, $ 2,119 M
  • 60-Month Beta 0.67
  • Price/Sales 2.83
  • Price/Cash Flow 9.60
  • Price/Book 1.84
Trade PFE with:

Options Overview Details

View History
  • Implied Volatility 31.50% ( +0.46%)
  • Historical Volatility 20.90%
  • IV Percentile 93%
  • IV Rank 85.70%
  • IV High 33.73% on 10/27/23
  • IV Low 18.16% on 05/13/24
  • Put/Call Vol Ratio 0.24
  • Today's Volume 280,329
  • Volume Avg (30-Day) 118,159
  • Put/Call OI Ratio 0.98
  • Today's Open Interest 2,871,081
  • Open Int (30-Day) 2,883,075

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.63
  • Number of Estimates 7
  • High Estimate 0.76
  • Low Estimate 0.50
  • Prior Year -0.17
  • Growth Rate Est. (year over year) +470.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.24 +6.91%
on 10/04/24
30.43 -0.79%
on 10/09/24
+0.78 (+2.65%)
since 09/09/24
3-Month
27.80 +8.60%
on 07/10/24
31.54 -4.28%
on 07/30/24
+2.47 (+8.91%)
since 07/09/24
52-Week
25.20 +19.80%
on 04/26/24
33.92 -11.00%
on 10/16/23
-3.01 (-9.07%)
since 10/09/23

Most Recent Stories

More News
Why Pfizer Stock Popped Today

The sharp, sudden entry of an activist investor is raising hopes that change might come to the company.

PFE : 30.19 (+3.46%)
S&P 500 Climbs to a Record High on Expectations of Easing US Inflation

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up by +0.71%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +1.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.80%. Stocks...

AMAT : 205.06 (+2.08%)
GOOGL : 161.86 (-1.53%)
GTLB : 53.84 (+7.74%)
AVGO : 185.95 (+2.89%)
ADI : 233.24 (+1.67%)
TXN : 204.97 (+1.36%)
$IUXX : 20,268.86 (+0.80%)
PFE : 30.19 (+3.46%)
ASML : 845.90 (+2.63%)
RJF : 128.28 (+2.71%)
ZNZ24 : 112-070 (+0.01%)
PDD : 141.47 (-2.34%)
BMY Buoyed by Recent Regulatory Updates: How to Play the Stock?

Last week, Bristol Myers BMY obtained FDA approval for a label expansion of its blockbuster immuno oncology drug Opdivo (nivolumab).The FDA approved Opdivo as a perioperative treatment regimen for adults...

MRK : 110.27 (+1.61%)
PFE : 30.19 (+3.46%)
BMY : 52.80 (+0.61%)
Stocks Push Higher Ahead of Thursday’s US CPI Report

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.37%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.45%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.40%. Stocks today are moderately...

GOOGL : 161.86 (-1.53%)
GTLB : 53.84 (+7.74%)
GL : 107.20 (+2.92%)
$SPX : 5,792.04 (+0.71%)
EXPD : 121.26 (-0.12%)
$IUXX : 20,268.86 (+0.80%)
PFE : 30.19 (+3.46%)
RJF : 128.28 (+2.71%)
QQQ : 493.15 (+0.79%)
ZNZ24 : 112-070 (+0.01%)
PDD : 141.47 (-2.34%)
ALAB : 61.22 (+15.60%)
3 High-Yield Stocks for Growing Dividend Income

Each of these companies boasts a solid track record of paying and raising dividends, with yields exceeding 5%.

BCE : 33.31 (-0.60%)
PFE : 30.19 (+3.46%)
ARCC : 21.01 (unch)
Billionaire Ken Griffin Just Bought 7.9 Million Shares of This Beaten-Down Pharmaceutical Stock as It Eyes the Weight Loss Market

Ken Griffin's Citadel continues to add to its position in Pfizer.

PFE : 30.19 (+3.46%)
As a Billionaire Activist Takes a Stake, Is Now the Time to Buy Pfizer Stock?

Starboard will look to turn around the struggling pharma company.

PFE : 30.19 (+3.46%)
Is This Overlooked Dividend Stock Yielding Almost 6% a Good Turnaround Play?

Despite its dividend yield of nearly 6%, Pfizer stock has failed to win over investors and is in the red YTD. Can the stock finally stage a turnaround, as activist investor Starboard Value has reportedly...

PTON : 4.72 (+3.06%)
NKE : 82.45 (+2.08%)
CMG : 57.93 (-0.09%)
PFE : 30.19 (+3.46%)
SB : 4.80 (-3.03%)
DIS : 93.60 (+1.18%)
Pfizer Receives $1 Billion From Starboard Value, Stock Rises

Shares of Pfizer PFE rose 2.17% on Oct. 7 after a report from The Wall Street Journal stated that activist investor Starboard Value has taken a roughly $1 billion stake in the company.Investors cheered...

NVO : 117.00 (-0.17%)
LLY : 919.74 (+0.66%)
PFE : 30.19 (+3.46%)
Company News for Oct 8, 2024

Shares of Pfizer Inc. (PFE) rose 2.2% on reports that activist investor Starboard Value acquired around $1 billion stake in the company in a bid to stage a turnaround for the ailing company.Wynn Resorts,...

GOOGL : 161.86 (-1.53%)
APD : 313.97 (+1.16%)
WYNN : 104.15 (+1.23%)
PFE : 30.19 (+3.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 32.04
2nd Resistance Point 31.24
1st Resistance Point 30.71
Last Price 30.19
1st Support Level 29.38
2nd Support Level 28.58
3rd Support Level 28.05

See More

52-Week High 33.92
Fibonacci 61.8% 30.59
Last Price 30.19
Fibonacci 50% 29.56
Fibonacci 38.2% 28.53
52-Week Low 25.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar